Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Liver Diseases × Ribavirin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hepatitis C 3 Lymphoma, Non-Hodgkin 2 Precancerous Conditions 1 Melanoma 1 Malignant Solid Tumor 1 Lymphoma, Mantle-Cell 1 Lymphoma, Follicular 1 Lymphoma 1 Liver Neoplasms 1 Liver Diseases 1 Leukemia, Myeloid, Acute 1 Infections 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

linifanib 1 ledipasvir, sofosbuvir drug combination 1 genexol-PM 1 Sunitinib 1 Sorafenib 1 Sofosbuvir 1 Ribavirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02717949 2019-01-08

Optimal

University of Texas Southwestern Medical Center

Phase 4 Terminated

Hepatitis C, Liver Diseases, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡